Eligible patients may increasingly prefer an annual fecal immunochemical test (FIT) or fecal occult blood test (FOBT) over a colonoscopy, according to new data.1
In findings from the colorectal cancer screening CONFIRM trial, investigators reported that preference for lesser invasive screening methods has been popularizing among a population of US veterans recruited into the US-based assessment—and that FIT or FOBT have already surpassed colonoscopies as the most popular method of colorectal cancer screening in some regions.